An Exploratory Analysis of the Association Between EORTC-QLQ C30 Domains and Progression Free/Overall Survival in Advanced Melanoma After 12 Weeks of Treatment on Ipilimumab Compared to Gp100 in a Phase III Clinical Trial
Abstract
Authors
D. Lee B. Harvey A.F. Gaudin B. Gueron B. Bregman C. Lebbe F. Bonnetain I. Borget